← Evidence map

ArticleCancers2026

Minimal Efficacy of Single-Agent Anti-PD-(L)1 Re-Exposure in Anti-PD-(L)1-Refractory Merkel Cell Carcinoma: A Retrospective Cohort Study of 16 Patients.

Peter Y Ch'en et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Minimal Efficacy of Single-Agent Anti-PD-(L)1 Re-Exposure in Anti-PD-(L)1-Refractory Merkel Cell Carcinoma: A Retrospective Cohort Study of 16 Patients. | OpenQuestion